蜜芽传媒

In 1960, FDA scientist Frances Oldham Kelsey is tasked with approving an application for a mild sedative to be sold in America. The drug is popular across Europe and is touted to be free of side effects, so this should be a routine job. But something doesn't sit right with Frances and she starts digging for evidence to support her suspicions. As the pharmaceutical company pushes for speedy approval, Frances discovers the drug's devastating impact. Katie Hafner, host of The Lost Women of Science podcast, joins Tim to explain why America should remember the woman who kept Thalidomide off the market.